The CXCR4-CXCL12 axis could promote angiogenesis and recruit myeloid bone marrow-derived cells to facilitate tumor recurrence and metastasis, thus mediating resistance to conventional as well as targeted therapies. Here, CXCR4 is linked to neoplasm.